Element Capital Management LLC Protagonist Therapeutics, Inc Transaction History

Element Capital Management LLC

  • $10.1 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019
SELL
$6.3 - $10.44 $123,876 - $205,281
-19,663 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$6.82 - $11.26 $239,068 - $394,708
-35,054 Reduced 64.06%
19,663 $202,000
Q2 2018

Aug 14, 2018
BUY
$5.99 - $9.1 $205,882 - $312,776
34,371 Added 168.93%
54,717 $368,000
Q1 2018

May 15, 2018
BUY
$8.46 - $23.08 $172,127 - $469,585
20,346 New
20,346 $175,000

Others Institutions Holding PTGX

# of Institutions
254
Shares Held
58M
Call Options Held
226K
Put Options Held
218K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.4B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email